Decreased angiotensin II receptors mediate decreased vascular response in hepatocellular cancer

Annals of Surgery
Y WuJ V Sitzmann

Abstract

The authors' objective was to determine the origin of the diminished pressor responsiveness of angiotensin II infusion in hepatoma by evaluating angiotensin II receptor status in normal liver, hepatoma tumor, and cultured hepatocytes and H4IIE cells. Hepatocellular cancer is a highly vascular tumor, where the neovasculature is unique in that it arises only from the hepatic arterial circulation, whereas normal liver has both hepatic arterial and portal venous blood supply. The tumor neovasculature is also characterized by an abnormal vascular reactivity to vasoconstrictors, including the response to angiotensin II. The altered response of tumor vasculature to angiotensin II offers a potential therapeutic opportunity for modulation of tumor blood flow. However, the origin of the decreased vascular response is unknown. The authors evaluated the hepatic vascular response to angiotensin II infusion by determining hepatic arterial blood flow to normal liver and to tumor by means of radioactive microspheres. The angiotensin II receptor status in the normal liver, hepatoma tumor, and cultured hepatocytes and H4IIE cells was determined br radioligand binding analysis and in cryostat sections derived from normal liver and hepatoma tumor ...Continue Reading

References

Aug 1, 1992·Journal of Hypertension·T InagamiH Furuta
Jan 1, 1991·Archives of Orthopaedic and Trauma Surgery·W R HogeboomH Schraffordt Koops
Sep 1, 1989·The Journal of Surgical Research·T T ThanL B Grochow
Oct 1, 1981·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·G S Wood, R Warnke
Mar 15, 1980·American Journal of Obstetrics and Gynecology·A D BerssenbruggeJ H Rankin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.